Evidence map›Paper›PMID 35016221›Full record

ArticleCarcinogenesis2022

Commentary: Role and communications of cancer hazard determinations.

Jonathan M Samet, Amy Berrington de Gonzalez, Ruth M Lunn, Mary K Schubauer-Berigan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Carcinogenesis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jonathan M SametColorado School of Public Health, Aurora, CO, USA.ORCID 0000-0001-5676-9175
Amy Berrington de GonzalezNational Cancer Institute, Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA.
Ruth M LunnNational Institute of Environmental Health Sciences, Division of the National Toxicology Program, Research Triangle Park, NC, USA.
Mary K Schubauer-BeriganInternational Agency for Research on Cancer, Evidence Synthesis and Classification Branch, Lyon, CEDEX, France.

Funding

NCI NIH HHSNIEHS NIH HHSNIH HHSWorld Health Organization 001
6 · The paper itself

Abstract

This commentary is written in response to a recent commentary in Carcinogenesis that provides several viewpoints on the International Agency for Research on Cancer's (IARC) Monographs program on cancer hazard identification. This commentary offers an alternative viewpoint of the role of cancer hazard identification derived from cancer epidemiology studies in risk characterization, as well as clarification on the previous commentary's interpretation of the purpose of the Monographs and other programs of cancer hazard identification and how IARC communicates the findings of the Monographs.

Indexed as

CarcinogensNeoplasmsCarcinogenesisHumansInternational AgenciesCarcinogens

Identifiers

PMID35016221
PMCPMC8947230

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.